None listed
Conditions
Brief summary
This pilot study will explore the immediate and short term effects of individualised physiotherapy manual therapy treatment during the prodromal phase or beginning (up to 4 hours) of a migraine attack episode. Our hypothesis is that delivery of individualised physiotherapy manual therapy treatment in this period will help to reduce symptoms and burden of the single migraine attack in the immediate and short term.
Interventions
All participants will be assessed for any cervical musculoskeletal disorder and heightened pain sensitivity and be provided with individualised physiotherapy treatment by a musculoskeletal physiotherapist experienced in treating patients with headaches and heightened pain sensitivity. All participants will be educated on how to recognise when they are in the prodromal phase (up to 24 hours before a migraine attack) and to contact the treating physiotherapist when they are in the prodromal phase.
All participants will be assessed for any cervical musculoskeletal disorder and heightened pain sensitivity and be provided with individualised physiotherapy treatment by a musculoskeletal physiotherapist experienced in treating patients with headaches and heightened pain sensitivity. All participants will be educated on how to recognise when they are in the prodromal phase (up to 24 hours before a migraine attack) and to contact the treating physiotherapist when they are in the prodromal phase. Education will be delivered face-to-face with the physiotherapist over about 10 minutes with the help of visual aids in interactive discussions with each participant to allow questions and confirmation of understanding. No booklets will be provided. When contacted by the participant, the physiotherapist will confirm that they are within the prodromal period through discussion of their symptom presentation. Treatment will be provided as soon as possible from the beginning of the prodromal phase, or up to 4 hours into the migraine attack. The duration of the intervention period will be up till the end of the study: 17th September 2024. One session of treatment will be performed in person, face to face at the university clinic, for each prodromal period. There are no maximum number of sessions over the intervention period. All participants will be provided individualised treatment that consists of manual therapy techniques such as spinal mobilisations, manipulation and gentle soft tissue techniques, all aiming at reducing current pain levels and any associated symptoms. Treatment will be personalised at the discretion of the treating physiotherapist according to the individual’s presenting condition, response to pain relieving techniques and their personal preferences. All participants will be contacted at the end of the study to confirm if treatment was sought and attended for all prodromal periods during the study period. All sessions attended will be recorded electronically with treatment notes.
Sponsors
The University of Queensland
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
- Classified as low frequency episodic migraine (8 or less days of headache/month) according to ICHD-3 criteria. - Experiencing or about to experience migraine attack and able to attend university clinic for treatment just prior to onset of attack (up to 24 hours prior) and up to 4 hours after the onset of the migraine attack.
Exclusion criteria
Presentation of current episode of headache, as reported by the participant, does not fit ICHD-3 classification criteria for migraine.
Outcome results
None listed